These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 345780)

  • 21. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
    Coleman DL; Root RK; Ryan JL
    J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the plasminogen activator activity of macrophage tumor cell lines.
    Hamilton JA; Moore MA
    Int J Immunopharmacol; 1980; 2(4):353-62. PubMed ID: 7193652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of phagocytosis in the activation of macrophages.
    Schnyder J; Baggiolini M
    J Exp Med; 1978 Dec; 148(6):1449-57. PubMed ID: 722242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage cell lines behave as activated macrophages in the production and regulation of plasminogen activator.
    Jones CM; Goldfarb RH; Holden HT
    Cancer Invest; 1983; 1(3):207-13. PubMed ID: 6686788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic nucleotides, possible intracellular mediators of macrophage activation and secretory processes.
    Foster SJ
    Agents Actions; 1980 Dec; 10(6):556-61. PubMed ID: 6267914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteases induce secretion of collagenase and plasminogen activator by fibroblasts.
    Werb Z; Aggeler J
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1839-43. PubMed ID: 205872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of migration inhibition factor (MIF) and an inducer of plasminogen activator (IPA) by subsets of T cells in MLC.
    Newman W; Gordon S; Hämmerling U; Senik A; Bloom BR
    J Immunol; 1978 Mar; 120(3):927-31. PubMed ID: 147297
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of macrophage products on the release of plasminogen activator, collagenase, beta-glucuronidase and prostaglandin E2 by articular chondrocytes.
    Evêquoz V; Schnyder J; Trechsel U; Baggiolini M; Fleisch H
    Biochem J; 1984 Apr; 219(2):667-77. PubMed ID: 6331394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanisms of macrophage activation. I. Destruction of intracellular Leishmania enriettii in macrophages activated by cocultivation with stimulated lymphocytes.
    Mauel J; Buchmüller Y; Behin R
    J Exp Med; 1978 Aug; 148(2):393-407. PubMed ID: 308979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolytic enzymes released by liver macrophages may promote hepatic injury in a rat model of hepatic damage.
    Tanner A; Keyhani A; Reiner R; Holdstock G; Wright R
    Gastroenterology; 1981 Apr; 80(4):647-54. PubMed ID: 7009306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia.
    Ezekowitz RA; Austyn J; Stahl PD; Gordon S
    J Exp Med; 1981 Jul; 154(1):60-76. PubMed ID: 7019381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of macrophages as effector cells.
    Huber H; Ledochowski M; Michlmayr G
    Haematol Blood Transfus; 1981; 27():39-48. PubMed ID: 6276272
    [No Abstract]   [Full Text] [Related]  

  • 33. Macrophage activation and nonspecific immunity.
    Allison AC
    Int Rev Exp Pathol; 1978; 18():303-46. PubMed ID: 350790
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of serum components of patients with liver diseases on hepatocyte cytotoxicity and plasminogen activator production of activated macrophages].
    Sawai H; Mizoguchi Y; Tsutsui H; Miyazima Y; Ikemoto Y; Arai T; Sakagami Y; Higashimori T; Monna T; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1983 May; 80(5):1162-7. PubMed ID: 6355579
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of the neutral protease activity of macrophages treated with asbestos in vitro.
    Hamilton JA
    Environ Health Perspect; 1983 Sep; 51():103-8. PubMed ID: 6416822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphokine-induced secretion of plasminogen activator by murine macrophages.
    Klimetzek V; Sorg C
    Eur J Immunol; 1977 Mar; 7(3):185-7. PubMed ID: 862658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of macrophage immune and nonimmune receptor-mediated phagocytosis by a low molecular weight soluble factor from resident thymocytes.
    Coleman DL; Culver KE; Ryan JL
    J Immunol; 1984 Dec; 133(6):3121-7. PubMed ID: 6386982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor.
    Lin HS; Gordon S
    J Exp Med; 1979 Aug; 150(2):231-45. PubMed ID: 313429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elastase secretion by stimulated macrophages. Characterization and regulation.
    Werb Z; Gordon S
    J Exp Med; 1975 Aug; 142(2):361-77. PubMed ID: 167096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of phagocytosis of mineral dusts on elastase secretion by alveolar and peritoneal exudative macrophages.
    White R; Kuhn C
    Arch Environ Health; 1980; 35(2):106-9. PubMed ID: 6899953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.